Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys

Prednisone (Pred) and Deflazacort (Dfz) are commonly used glucocorticoids (GCs) for Duchenne muscular dystrophy (DMD) treatment and management. While GCs are known to delay the loss of ambulation and motor abilities, chronic use can result in onerous side effects, e.g., weight gain, growth stunting,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawalbeh, Shefa, Samsel, Alison, Gordish-Dressman, Heather, Hathout, Yetrib, Dang, Utkarsh J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720112/
https://www.ncbi.nlm.nih.gov/pubmed/33053810
http://dx.doi.org/10.3390/jpm10040164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720112/
https://www.ncbi.nlm.nih.gov/pubmed/33053810
http://dx.doi.org/10.3390/jpm10040164

Ejemplares similares